Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Clinical Chemistry Analyzer Offers Increased Efficiency and Productivity

By LabMedica International staff writers
Posted on 02 Mar 2011
The latest addition to a series of clinical chemical analyzers provides increased efficiency and productivity. More...


The RX series of four clinical chemistry analyzers provide quality results at every phase of clinical development. The analyzers offer an extensive test menu enabling laboratories to avoid the costly outsourcing of routine safety testing.

The latest addition to the series is the RX suzuka, a fully automated random access analyzer capable of carrying out up to 1200 tests per hour including ISEs. The RX monza is the smallest of the series; it is a semi- automated clinical analyzer ideal for low throughput testing in clinical, research laboratories, and specialized clinics. The RX daytona is a compact benchtop fully automated clinical analyzer with a throughput of 180 photometric tests and 270 ISE tests per hour. The RX imola is a fully automated and random access benchtop analyzer capable of performing 400 photometric tests and 240 ISE tests per hour.

Each system requires only a small sample volume. Reagent volume required is also low, reducing cost per test. The RX Series require no extra consumables--for example, permanent pyrex cuvettes are used, providing considerable cost savings.

Randox Pharma Services ( Crumlin , UK) markets the RX series of analyzers. The company also offers an extensive test menu consisting of over 120 enzymatic, substrate, and immunoturbidimetric assays.

In addition to the analyzers, a Quality Control (QC) package is provided. Randox quality controls cover over 170 parameters and are of high quality, accurate, and stable ensuring valid clinical results. Customized QC is also available in addition to RIQAS, the largest global EQA scheme.

Related Links:

Randox Pharma Services





Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Automated Immunoassay Analyzer
SuperFlex™
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.